John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
TETRA Technologies
TTI
$1.01B
| $4.22M | 0.02% |
+561,617
| New | +$4.37M |
|
727
CALL
3M
MMM
$92.2B
| $4.22M | 0.02% |
+33,488
| New | +$4.3M |
|
728
Inogen
INGN
$147M
| $4.21M | 0.02% |
105,139
+72,106
| +218% | +$3.05M |
|
729
PUT
ConocoPhillips
COP
$160B
| $4.2M | 0.02% |
90,000
+68,000
| +309% | +$3.55M |
|
730
LXP Industrial Trust
LXP
$3.6B
| $4.18M | 0.02% |
104,514
+43,470
| +71% | +$1.84M |
|
731
Lesaka Technologies
LSAK
$393M
| $4.17M | 0.02% |
309,015
-14,400
| -4% | -$226K |
|
732
RE/MAX Holdings
RMAX
$247M
| $4.17M | 0.02% |
+111,907
| New | +$4.18M |
|
733
Camden Property Trust
CPT
$11B
| $4.17M | 0.02% |
+54,318
| New | +$4.14M |
|
|
ORBK
734
DELISTED
Orbotech Ltd
ORBK
| $4.17M | 0.02% |
188,294
+71,799
| +62% | +$1.34M |
|
735
Central Pacific Financial
CPF
$976M
| $4.17M | 0.02% |
189,127
-61,904
| -25% | -$1.37M |
|
|
VRN
736
DELISTED
Veren
VRN
| $4.16M | 0.02% |
356,809
+275,766
| +340% | +$3.63M |
|
737
PUT
AbbVie
ABBV
$468B
| $4.15M | 0.02% |
+70,000
| New | +$4.03M |
|
|
IPHI
738
DELISTED
INPHI CORPORATION
IPHI
| $4.14M | 0.02% |
153,404
+144,350
| +1,594% | +$4.13M |
|
739
Ericsson
ERIC
$33.3B
| $4.14M | 0.02% |
430,939
+67,479
| +19% | +$657K |
|
740
Adeia
ADEA
$2.92B
| $4.13M | 0.02% |
520,653
-303,277
| -37% | -$2.65M |
|
741
HUB Group
HUBG
$2.43B
| $4.12M | 0.02% |
+250,234
| New | +$4.66M |
|
742
Match Group
MTCH
$9.53B
| $4.12M | 0.02% |
+303,821
| New | +$4.25M |
|
743
PUT
SLB Ltd
SLB
$80B
| $4.12M | 0.02% |
59,000
+18,000
| +44% | +$1.35M |
|
|
COHR
744
DELISTED
Coherent Inc
COHR
| $4.09M | 0.02% |
62,828
+58,428
| +1,328% | +$3.6M |
|
745
Avnet
AVT
$7.08B
| $4.09M | 0.02% |
95,388
+67,650
| +244% | +$3.04M |
|
|
IPHS
746
DELISTED
Innophos Holdings, Inc.
IPHS
| $4.08M | 0.02% |
140,684
+71,369
| +103% | +$2.51M |
|
747
Evertec
EVTC
$1.78B
| $4.07M | 0.02% |
242,906
+152,300
| +168% | +$2.69M |
|
748
Anika Therapeutics
ANIK
$285M
| $4.05M | 0.02% |
106,104
+54,840
| +107% | +$2.1M |
|
749
Insperity
NSP
$2B
| $4.04M | 0.02% |
167,850
+150,108
| +846% | +$3.4M |
|
|
HZNP
750
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.04M | 0.02% |
+186,349
| New | +$3.63M |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.